AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute

News
Article

During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.

This transcript has been lightly edited for clarity.

T.Y. Alvin Liu, MD: Hello everyone. My name is Alvin Liu. I'm a retina specialist, and I'm on the faculty at the Wilmer Eye Institute, Johns Hopkins Medicine. Today, I have the pleasure of introducing to you our new AI Center at Wilmer.

Recently, we received a very generous donation of $10 million from Dr James B Gills and Mrs. Gills to establish an endowed AI Center at Wilmer, and this will be the first endowed AI center at the Johns Hopkins School of Medicine. I have the honor of being asked to be the inaugural director of the center, together with the endowed professorship. This center will be guided by 3 important core values. Number 1, it will be open to all Wilmer faculty members. Number 2, we will seek to be proactively collaborative with other academic centers, industry and foundations. And Number 3, we will be ready to pivot rapidly in response to the evolving AI landscape. 

In terms of specific initiatives, there are 3 major ones. First, we would like to provide a steady stream of computer science talents in terms of AI to our Wilmer faculty members. Number 2, we would like to establish a permanent data storage site to create a digital twin for all the images and videos at Wilmer. And Number 3, we will establish centralized and steady compute resources in terms of access to GPUs. We have many more initiatives to come, so stay tuned and thank you very much.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.